Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on BE Acid. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN110002989B reveals a high-selectivity synthesis for 5-bromo-2-chlorobenzoic acid, offering cost reduction and superior purity for SGLT-2 inhibitor manufacturing.
Patent CN112194603B reveals a green oxidation route for key HPPD inhibitor intermediates, offering significant cost reduction and supply chain reliability for agrochemical manufacturers.
Patent CN1119321C details a scalable Reformatsky route for ethyl 3S-amino-4-pentynoate, offering high optical purity and cost-effective manufacturing for pharmaceutical intermediates.
Novel patent method for 2-hydroxyl 3 6-dichlorobenzoic acid reduces pressure requirements and enhances supply chain reliability for agrochemical manufacturers.
Novel green synthesis route for fluoroquinolone intermediates offering high purity and scalable production capabilities for global pharma supply chains.
Novel synthesis patent CN118666668A offers high purity above 99% and scalable purification for pharmaceutical intermediates supply chain stability and cost efficiency in global manufacturing.
Discover the patented CN101817766A method for producing metanilic acid. Achieve 100% conversion with recyclable Pd/C catalysts, eliminating iron sludge and reducing costs for dye and pharma intermediates.
Patent CN102127021B details a novel solubilization method for bisbenzimidazole salts ensuring high purity and scalable manufacturing for global pharmaceutical supply chains.
Patent CN112094182A reveals a green molecular sieve catalyzed route for benzocyclohexanones, offering cost reduction and supply chain reliability for API manufacturing.
Patent CN112898368B reveals Pd-catalyzed route for obeticholic acid intermediate, offering mild conditions and supply chain stability for pharma manufacturing.
Patent CN104910034A details a novel ruthenium-catalyzed synthesis for high-purity alpha-beta-diamino acid derivatives, offering cost reduction in pharmaceutical intermediate manufacturing.
Patent CN119661412A reveals a high-yield synthesis route for Upadacitinib intermediates, offering significant cost reduction and scalable manufacturing solutions for global supply chains.
Patent CN104876995B details a 5-step Swern oxidation route for 6ECDCA. Offers high purity, reduced waste, and scalable manufacturing for global supply chains.
Novel copper-catalyzed method for 2-phenylthiobenzoic acid production. High yield, scalable, eco-friendly pharmaceutical intermediate supply chain solution for global buyers.
Patent CN102757367A details a cost-effective splitting process for DL-benzene ethyl sulfonic acid using L-HPG, offering high purity and supply chain stability for pharmaceutical intermediates.
Patent CN106046095B reveals mild Obeticholic acid synthesis. Eliminates LDA cryogenic steps. Enables cost reduction in pharmaceutical intermediates manufacturing.
Efficient synthesis of 5-(trifluoromethoxy)-1H-benzo[d]imidazole-2-carboxylic acid via iron reduction and permanganate oxidation. Ideal for API intermediates.
Patent CN113801045A details a novel Pd-catalyzed carbonylation route for 2-nitro-4-methylsulfonylbenzoic acid, offering safer, high-purity production for agrochemical supply chains.
Patent CN101362710A details a clean catalytic hydrogenation route for aminobenzenesulfonic acid, offering superior purity and eliminating iron mud waste for dye intermediates.
Patent CN116120325B reveals a novel preparation method for Ketorolac EP Impurity D with high purity and simplified operations for reliable pharmaceutical intermediates supply chains.